H. Thomas Watkins's Insider Trades & SAST Disclosures

H. Thomas Watkins's most recent trade in Horizon Therapeutics Plc was a trade of 3,913 Restricted Stock Units done . Disclosure was reported to the exchange on April 28, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Horizon Therapeutics Plc
Thomas H. Watkins Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2023 3,913 0 - - Restricted Stock Units
Horizon Therapeutics Plc
Thomas H. Watkins Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2023 3,913 29,124 (0%) 0% - Ordinary Shares
Vanda Pharmaceuticals Inc
Thomas H. Watkins Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jun 2022 15,000 0 - - Stock Option (Right to Buy)
Vanda Pharmaceuticals Inc
Thomas H. Watkins Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.15 per share. 02 Jun 2022 15,000 69,505 (0%) 0% 4.2 62,250 Common Stock
Vanda Pharmaceuticals Inc
Thomas H. Watkins Director Sale of securities on an exchange or to another person at price $ 9.90 per share. 02 Jun 2022 6,441 63,064 (0%) 0% 9.9 63,779 Common Stock
Horizon Therapeutics Plc
Thomas H. Watkins Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2022 4,223 75,164 (0%) 0% - Ordinary Shares
Horizon Therapeutics Plc
Thomas H. Watkins Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 28 Apr 2022 4,223 0 - - Restricted Stock Units
Horizon Therapeutics Plc
Thomas H. Watkins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Apr 2022 3,913 3,913 - - Restricted Stock Units
Vanda Pharmaceuticals Inc
H. Thomas Watkins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 10,000 10,000 - - Stock Option (Right to Buy)
Vanda Pharmaceuticals Inc
H. Thomas Watkins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Jun 2021 5,000 54,505 (0%) 0% 0 Common Stock
Horizon Therapeutics Plc
H. Thomas Watkins Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Apr 2021 11,098 0 - - Restricted Stock Units
Horizon Therapeutics Plc
H. Thomas Watkins Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 29 Apr 2021 11,098 70,941 (0%) 0% - Ordinary Shares
Horizon Therapeutics Plc
H. Thomas Watkins Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Apr 2021 4,223 4,223 - - Restricted Stock Units
Vanda Pharmaceuticals Inc
H. Thomas Watkins Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.11 per share. 16 Feb 2021 15,000 55,323 (0%) 0% 7.1 106,650 Common Stock
Vanda Pharmaceuticals Inc
H. Thomas Watkins Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 16 Feb 2021 15,000 0 - - Stock Option (Right to Buy)
Vanda Pharmaceuticals Inc
H. Thomas Watkins Director Sale of securities on an exchange or to another person at price $ 18.54 per share. 16 Feb 2021 5,818 49,505 (0%) 0% 18.5 107,856 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades